Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus, Pimecrolimus, and Corticosteroids: Protopic JOint European Longitudinal Lymphoma and skin cancer Evaluation (JOELLE) Study

Documents

Study protocol

Initial protocol

Protopic JOELLE Protocol Final 30Jun2017_Redacted

Study results

Study results

JOELLE Final Report_Final-20Sep2019_Abstract_Redacted

Study report

Study report

JOELLE Final Report_Final V1-2_5Mar2020_Signed_Redacted.pdf

JOELLE StudyReport_ LIST OF ERRATA.pdf

Other information

Study, other information

Annex5_DoIForm_Additional_Feb2019

Annex5_DolForm_Additional_Mar2019

Publications

Study publications

Long-term risk of skin cancer and lymphoma in users of topical tacrolimus and p…

To what extent are topical tacrolimus or pimecrolimus associated with increased…

Case validation of cutaneous lymphoma to minimize protopathic bias

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

This study has been awarded the ENCePP seal

Conflicts of interest of investigators

Annex5_DoIForm_ALL

Composition of steering group and observers

JOELLE_NoSteeringGroup

Signed code of conduct

2018-0047_Declaration_EUPAS21769

Signed code of conduct checklist

2018-0047-Checklist CoC_EUPAS21769

Signed checklist for study protocols

2018-0047_Checklist for Study Protocols_EUPAS21769